Literature DB >> 26602943

Regulation of inflammatory and angiogenesis mediators in a functional model of decidualized endometrial stromal cells.

Amélie Bourdiec1, Syed-Furquan Ahmad2, Asmaa Lachhab2, Ali Akoum2.   

Abstract

The mechanisms involving the expression of interleukin (IL) 1 family members in the process of preparing the endometrium to receive an embryo remain unclear. In this study, decidualization differentially skewed the balance of IL1 family receptor expression in a pattern that increases endometrial stromal cell receptivity to IL1, IL18 and IL33. Additionally, endometrial cells showed increased expression of homeobox HOXA10 and HOXA11 and LIFR, which are known to be involved in endometrial embryo receptivity. Further analyses of decidual endometrial cells revealed a significant increase in the release of potent proinflammatory, remodelling and angiogenic factors implicated in the embryo invasion process, such as VEGF (P = 0.0305), MMP9 (P = 0.0003), TIMP3 (P = 0.0001), RANTES (P = 0.0020), MCP1 (P = 0.0001) and MIF (P = 0.0068). No significant changes in endogenous IL1B secretion were observed. Decreased secretion of IL18 and decidualization increased secretion of IL33. These findings reveal a significant modulation of endometrial cell receptivity to IL1 family members during endometrial stromal cell decidualization, and suggest that the involvement of IL1 family members is important in physiological processes of endometrial receptivity, including adaptive immunology. This may be relevant to establishing a favourable uterine microenvironment for embryo implantation.
Copyright © 2015 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  angiogenesis; decidualization; endometrium; inflammatory; interleukin 1 family

Mesh:

Substances:

Year:  2015        PMID: 26602943     DOI: 10.1016/j.rbmo.2015.09.011

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  7 in total

1.  Development and utilization of human decidualization reporter cell line uncovers new modulators of female fertility.

Authors:  Meade Haller; Yan Yin; Liang Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

2.  Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase.

Authors:  Lu Zhang; Ying Li; Chun-Yi Guan; Shi Tian; Xiao-Dan Lv; Jian-Hui Li; Xu Ma; Hong-Fei Xia
Journal:  Stem Cell Res Ther       Date:  2018-02-13       Impact factor: 6.832

3.  GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity.

Authors:  Song Guo; Zhichao Li; Li Yan; Yijuan Sun; Yun Feng
Journal:  Drug Des Devel Ther       Date:  2018-06-07       Impact factor: 4.162

4.  Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity.

Authors:  Chun Feng; Jin-Ming Shen; Ping-Ping Lv; Min Jin; Li-Quan Wang; Jin-Peng Rao; Lei Feng
Journal:  Int J Biol Sci       Date:  2018-07-27       Impact factor: 6.580

5.  Asynchronous Embryo Transfer Followed by Comparative Transcriptomic Analysis of Conceptus Membranes and Endometrium Identifies Processes Important to the Establishment of Equine Pregnancy.

Authors:  Charlotte Gibson; Marta de Ruijter-Villani; Stefan Bauersachs; Tom A E Stout
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

6.  Transcriptomic analysis of human endometrial stromal cells during early embryo invasion.

Authors:  Shuo Han; Minghui Liu; Shan Liu; Yuan Li
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 7.  Estrogen- and Progesterone (P4)-Mediated Epigenetic Modifications of Endometrial Stromal Cells (EnSCs) and/or Mesenchymal Stem/Stromal Cells (MSCs) in the Etiopathogenesis of Endometriosis.

Authors:  Dariusz Szukiewicz; Aleksandra Stangret; Carmen Ruiz-Ruiz; Enrique G Olivares; Olga Soriţău; Sergiu Suşman; Grzegorz Szewczyk
Journal:  Stem Cell Rev Rep       Date:  2021-01-07       Impact factor: 5.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.